<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02552927</url>
  </required_header>
  <id_info>
    <org_study_id>55472</org_study_id>
    <secondary_id>911</secondary_id>
    <nct_id>NCT02552927</nct_id>
  </id_info>
  <brief_title>Chest Shielding in Premature Infants During Phototherapy</brief_title>
  <acronym>SLIGHT</acronym>
  <official_title>Effect of Chest Shielding on the Incidence of Patent Ductus Arteriosus in Premature Infants Undergoing Phototherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infants will be randomized to either chest shielding with aluminum foil or chest shielding
      without aluminum foil while undergoing phototherapy for premature infants. The primary
      outcome is patent ductus arteriosus.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2015</start_date>
  <completion_date type="Actual">February 13, 2019</completion_date>
  <primary_completion_date type="Actual">February 13, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of symptomatic Patent ductus arteriosus</measure>
    <time_frame>During first 2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary Nitric oxide level</measure>
    <time_frame>During first 2 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of Chronic lung disease</measure>
    <time_frame>at 36 weeks post-menstrual age</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Retinopathy of Prematurity</measure>
    <time_frame>up to 44 weeks post-menstrual age</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Peak level of total serum bilirubin</measure>
    <time_frame>First 2 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Duration of Phototherapy</measure>
    <time_frame>First 2 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of intraventricular hemorrhage</measure>
    <time_frame>First 2 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of surgical ligation for patent ductus arteriosus</measure>
    <time_frame>First 4 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Patent Ductus Arteriosus in Premature Infants</condition>
  <arm_group>
    <arm_group_label>CALF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chest shield with aluminum foil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHIELD</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Chest shield without aluminum foil</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chest shield with aluminum foil (CALF)</intervention_name>
    <arm_group_label>CALF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SHIELD</intervention_name>
    <arm_group_label>SHIELD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  less or equal to 29 weeks or 1000g at birth

          -  Admitted to the NICU (Neonatal intensive care unit) within 24 hours after birth

          -  English speaking parents

        Exclusion Criteria:

          -  Congenital abnormalities

          -  Chromosomal disorders

          -  Cyanotic heart defects

          -  Nitric oxide

          -  Prophylactic phototherapy

          -  Unlikely to survive beyond 72 hours according to the attending neonatologist

          -  Do not require phototherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Weeks</minimum_age>
    <maximum_age>33 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javed Mannan, MD, MPH</last_name>
    <role>Study Director</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 17, 2015</study_first_submitted>
  <study_first_submitted_qc>September 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2015</study_first_posted>
  <last_update_submitted>September 4, 2019</last_update_submitted>
  <last_update_submitted_qc>September 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Sanjiv Amin</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>PDA</keyword>
  <keyword>Jaundice</keyword>
  <keyword>Phototherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

